Authors: Winston, DJ Antin, JH Wolff, SN Bierer, BE Small, T Miller, KB Linker, C Kaizer, H Lazarus, HM Petersen, FB Cowan, MJ Ho, WG Wingard, JR Schiller, GJ Territo, MC Jiao, J Petrarca, MA Tonetta, SA

Citation: Dj. Winston et al., A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation, BONE MAR TR, 28(2), 2001, pp. 187-196

Authors: Nash, RA Antin, JH Karanes, C Fay, JW Avalos, BR Yeager, AM Przepiorka, D Davies, S Petersen, FB Bartels, P Buell, D Fitzsimmons, W Anasetti, C Storb, R Ratanatharathorn, V

Citation: Ra. Nash et al., Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, BLOOD, 96(6), 2000, pp. 2062-2068

Authors: Bills, AC Green, WF Tsodikov, A Carey, MJ Perkins, SL Petersen, FB Beatty, PG Kelley, LL

Citation: Ac. Bills et al., Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumors, CYTOTHERAPY, 1(5), 1999, pp. 389-399

Authors: Adams, RH Christenson, JC Petersen, FB Beatty, PG

Citation: Rh. Adams et al., Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV, BONE MAR TR, 24(6), 1999, pp. 661-664